nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—COMT—Clearance of dopamine—SLC6A3—Gilles de la Tourette syndrome	0.422	0.422	CbGpPWpGaD
Entacapone—COMT—Biogenic Amine Synthesis—HDC—Gilles de la Tourette syndrome	0.335	0.335	CbGpPWpGaD
Entacapone—COMT—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.193	0.193	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.0147	0.0147	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.0113	0.0113	CbGpPWpGaD
Entacapone—COMT—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.0112	0.0112	CbGpPWpGaD
Entacapone—COMT—Metabolism—HDC—Gilles de la Tourette syndrome	0.00813	0.00813	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HDC—Gilles de la Tourette syndrome	0.00487	0.00487	CbGpPWpGaD
